Differential processing of influenza nucleoprotein in human and mouse cells
- PMID: 9521073
- DOI: 10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2-I
Differential processing of influenza nucleoprotein in human and mouse cells
Abstract
To investigate how early events in antigen processing affect the repertoire of peptides presented by MHC class I molecules, we compared the presentation of the influenza A nucleoprotein epitope 265-273 by HLA-A3 class I molecules in human and mouse cells. Mouse cells that express HLA-A3 failed to present the NP265-273 peptide when contained within the full-length nucleoprotein, to HLA-A3-restricted human cytotoxic T lymphocytes. However, when the epitope was generated directly in the cytosol using a recombinant vaccinia virus that expressed the nonamer peptide, mouse cells were recognized by HLA-A3-restricted CTL. Poor transport of the peptide by mouse TAP was not responsible for the defect as co-infection of mouse cells with recombinant vaccinia viruses encoding the full-length nucleoprotein and the human TAP1 and TAP2 peptide transporter complex failed to restore presentation. These results therefore demonstrate a differential processing of the influenza nucleoprotein in mouse and human cells. This polymorphism influences the repertoire of peptides presented by MHC class I molecules at the cell surface.
Similar articles
-
An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism.Eur J Immunol. 1993 Aug;23(8):1999-2004. doi: 10.1002/eji.1830230841. Eur J Immunol. 1993. PMID: 8344364
-
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.J Immunol. 1997 Oct 1;159(7):3195-202. J Immunol. 1997. PMID: 9317117
-
HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.J Immunol. 1993 Dec 1;151(11):5930-5. J Immunol. 1993. PMID: 7504010
-
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.Int J Cancer. 1996 Oct 9;68(2):251-8. doi: 10.1002/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D. Int J Cancer. 1996. PMID: 8900437
-
Recognition of influenza virus proteins by cytotoxic T lymphocytes.Immunol Res. 1987;6(1-2):80-100. doi: 10.1007/BF02918106. Immunol Res. 1987. PMID: 2442273 Review. No abstract available.
Cited by
-
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.J Virol. 1999 Jul;73(7):5320-5. doi: 10.1128/JVI.73.7.5320-5325.1999. J Virol. 1999. PMID: 10364278 Free PMC article.
-
The effect of season on inflammatory response in captive baboons.J Med Primatol. 2012 Dec;41(6):341-8. doi: 10.1111/j.1600-0684.2012.00560.x. Epub 2012 Aug 21. J Med Primatol. 2012. PMID: 22905903 Free PMC article.
-
Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.J Exp Med. 2000 Feb 7;191(3):503-14. doi: 10.1084/jem.191.3.503. J Exp Med. 2000. PMID: 10662796 Free PMC article.
-
Properties of MHC class I presented peptides that enhance immunogenicity.PLoS Comput Biol. 2013 Oct;9(10):e1003266. doi: 10.1371/journal.pcbi.1003266. Epub 2013 Oct 24. PLoS Comput Biol. 2013. PMID: 24204222 Free PMC article.
-
A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.Immunology. 2017 Apr;150(4):489-494. doi: 10.1111/imm.12702. Epub 2017 Jan 19. Immunology. 2017. PMID: 28004383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous